World's Best Scientists 2026 revealed!
Yoshihide Asano

Yoshihide Asano

D-Index & Metrics

Biology and Biochemistry

D-Index
71
Citations
15086
World Ranking
6771
National Ranking
451

Medicine

D-Index
71
Citations
15626
World Ranking
20023
National Ranking
641

Yoshihide Asano publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Yoshihide Asano sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 490 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Yoshihide Asano D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshihide Asano sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 71 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Yoshihide Asano is affiliated with the University of Tokyo in Japan and specializes in medicine, with a focus on pathology and forensic medicine, dermatology, immunology, oncology, and epidemiology. Their research addresses various aspects of systemic sclerosis and related diseases, contributing to a deeper understanding of autoimmune and inflammatory conditions.

Their recent publications include studies on systemic sclerosis and immune-mediated disorders, such as:

  • "Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial" (2020) published in The Lancet Respiratory Medicine
  • "Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial" (2021) published in The Lancet Rheumatology
  • "The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies" (2020) published in Journal of Clinical Medicine
  • "Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis" (2021) published in Nature Communications
  • "Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis" (2022) published in Science Immunology

Asano frequently co-authors work with several researchers including:

  • Shinichi Sato
  • Taku Fujimura
  • Yumi Kambayashi
  • Ayumi Yoshizaki
  • Ryo Amagai

Their publications appear predominantly in journals such as:

  • The Journal of Dermatology
  • European Journal of Dermatology
  • Case Reports in Oncology
  • Journal of Clinical Medicine
  • Experimental Dermatology

Yoshihide Asano's fields of study encompass medicine broadly, with an emphasis on pathology and forensic medicine and dermatology. Subfields also include immunology, oncology, and epidemiology, reflecting a multidisciplinary approach toward systemic diseases and skin-related disorders.

The main research topics covered in their work include:

  • Systemic Sclerosis and Related Diseases
  • Cutaneous lymphoproliferative disorders research
  • Inflammatory Myopathies and Dermatomyositis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Autoimmune Bullous Skin Diseases
  • Mast cells and histamine
  • Skin Diseases and Diabetes

Best Publications

  • Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.

    Yasuhito Hamaguchi;Masataka Kuwana;Kana Hoshino;Minoru Hasegawa

  • Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.

    Manabu Fujimoto;Yasuhito Hamaguchi;Kenzo Kaji;Takashi Matsushita

  • Increased Expression of Integrin αvβ3 Contributes to the Establishment of Autocrine TGF-β Signaling in Scleroderma Fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masatoshi Jinnin

  • Impaired Smad7-Smurf–mediated negative regulation of TGF-β signaling in scleroderma fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masahide Kubo

  • Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

    Satoshi Ebata;Ayumi Yoshizaki;Koji Oba;Kosuke Kashiwabara

  • Increased Expression of Integrin αvβ5 Induces the Myofibroblastic Differentiation of Dermal Fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masatoshi Jinnin

  • Endothelial Fli1 Deficiency Impairs Vascular Homeostasis : A Role in Scleroderma Vasculopathy

    Yoshihide Asano;Lukasz Stawski;Faye Hant;Kristin Highland

  • Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.

    Sayaka Shibata;Yayoi Tada;Carren Sy Hau;Aya Mitsui

  • IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model.

    Koichi Yanaba;Ayumi Yoshizaki;Yoshihide Asano;Takafumi Kadono

  • Vasculopathy in scleroderma

    Yoshihide Asano;Shinichi Sato

  • Adiponectin Regulates Cutaneous Wound Healing by Promoting Keratinocyte Proliferation and Migration via the ERK Signaling Pathway

    Sayaka Shibata;Yayoi Tada;Yoshihide Asano;Carren S. Hau

  • Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis

    Koichi Yanaba;Ayumi Yoshizaki;Yoshihide Asano;Takafumi Kadono

  • Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.

    Masatoshi Jinnin;Hironobu Ihn;Yoshihide Asano;Kenichi Yamane

  • Antagonistic Effects of TNF-α on TGF-β Signaling Through Down-Regulation of TGF-β Receptor Type II in Human Dermal Fibroblasts

    Kenichi Yamane;Hironobu Ihn;Yoshihide Asano;Masatoshi Jinnin

  • Future treatments in systemic sclerosis

    Yoshihide Asano

  • Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis

    Ayumi Yoshizaki;Koichi Yanaba;Asako Yoshizaki;Yohei Iwata

  • Transforming Growth Factor-β Regulates DNA Binding Activity of Transcription Factor Fli1 by p300/CREB-binding Protein-associated Factor-dependent Acetylation

    Yoshihide Asano;Joanna Czuwara;Maria Trojanowska

  • Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis

    Shinji Noda;Yoshihide Asano;Satoshi Nishimura;Takashi Taniguchi

  • Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Norihito Yazawa

  • IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell Lymphoma

    Tomomitsu Miyagaki;Makoto Sugaya;Hiraku Suga;Masahiro Kamata

Frequent Co-Authors

Shinichi Sato
Shinichi Sato University of Tokyo
Takafumi Kadono
Takafumi Kadono St. Marianna University School of Medicine
Hironobu Ihn
Hironobu Ihn Kumamoto University
Kunihiko Tamaki
Kunihiko Tamaki University of Tokyo
Masatoshi Jinnin
Masatoshi Jinnin Wakayama Medical University
Takashi Taniguchi
Takashi Taniguchi National Institute for Materials Science
Koichi Yanaba
Koichi Yanaba Jikei University School of Medicine
Maria Trojanowska
Maria Trojanowska Boston University
Manabu Fujimoto
Manabu Fujimoto Osaka University
Minoru Hasegawa
Minoru Hasegawa University of Fukui

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in studying Biology or Biochemistry, a wide range of online degrees can support your future career in the life sciences, healthcare, and related fields. For those fascinated by health and nutrition, pursuing an online nutritionist degree provides foundational knowledge in biology, chemistry, and human health, preparing you for diverse roles from wellness coaching to clinical research.

Students interested in healthcare management may explore top cahme accredited mha programs, which are designed for those aiming for leadership positions in hospitals, clinics, or public health organizations. For nurses seeking career advancement, there are flexible online dnp programs without clinicals—ideal for working professionals who want to deepen their expertise without the need for on-site practicum.

Ambitious students interested in healthcare leadership and policy might consider doctoral programs for healthcare administration, which focus on executive-level decision making, research, and organizational strategy. By leveraging these online pathways, students in biology and biochemistry fields can unlock rewarding, impactful careers in today’s rapidly evolving health sector.

Best Scientists Citing Yoshihide Asano

Trending Scientists

Recently Published Articles